BRPI0519212A2 - composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial - Google Patents

composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial

Info

Publication number
BRPI0519212A2
BRPI0519212A2 BRPI0519212-9A BRPI0519212A BRPI0519212A2 BR PI0519212 A2 BRPI0519212 A2 BR PI0519212A2 BR PI0519212 A BRPI0519212 A BR PI0519212A BR PI0519212 A2 BRPI0519212 A2 BR PI0519212A2
Authority
BR
Brazil
Prior art keywords
agents
pharmaceutical compositions
compositions containing
manifestation
oral disintegrating
Prior art date
Application number
BRPI0519212-9A
Other languages
English (en)
Inventor
Denis George Anthony Nelson
William Michael Nichols
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of BRPI0519212A2 publication Critical patent/BRPI0519212A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSIÇÕES FARMACÊUTICAS DE DESINTEGRAÇçO ORAL CONTENDO AGENTES DE MANIFESTAÇçO SENSORIAL. A presente invenção refere-se a composições que se desintegram na boca e contêm pelo menos um ingrediente farmacêutico sistemicamente ativo em uma quantidade terapeuticamente efetiva e, pelo menos, um agente de manifestação sensorial em uma quantidade efetiva de manifestação sensorial.
BRPI0519212-9A 2004-12-23 2005-12-12 composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial BRPI0519212A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63852604P 2004-12-23 2004-12-23
PCT/IB2005/003839 WO2006067593A1 (en) 2004-12-23 2005-12-12 Orally disintegrating pharmaceutical compositions with sensory cue agents

Publications (1)

Publication Number Publication Date
BRPI0519212A2 true BRPI0519212A2 (pt) 2009-01-06

Family

ID=36013364

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519212-9A BRPI0519212A2 (pt) 2004-12-23 2005-12-12 composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial

Country Status (10)

Country Link
US (1) US20060141031A1 (pt)
EP (1) EP1835886A1 (pt)
JP (1) JP2008525420A (pt)
CN (1) CN101102748A (pt)
AU (1) AU2005317739A1 (pt)
BR (1) BRPI0519212A2 (pt)
CA (1) CA2591747A1 (pt)
MX (1) MX2007007885A (pt)
RU (1) RU2007127999A (pt)
WO (1) WO2006067593A1 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10085954B2 (en) 2015-12-18 2018-10-02 The Procter & Gamble Company Quick dissolving diphenhydramine oral dosage form

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0618273A2 (pt) * 2005-11-02 2011-08-23 Teikoku Pharma Usa, Inc. formulações de dosagem oral de ibuprofeno organolepticamente aceitáveis, métodos de produção e uso das mesmas
US20080220029A1 (en) * 2007-03-05 2008-09-11 Charlene Ng Fast-dissolving/disintegrating film preparation having high proportion of active
EP2002733B1 (en) * 2007-06-08 2016-11-02 The Procter and Gamble Company Natural honey-containing compositions and method of preparation
US8323695B2 (en) 2007-08-13 2012-12-04 Mcneil-Ppc, Inc. Method for stabilizing phenylephrine
US9078824B2 (en) * 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
EP2100595A1 (en) * 2008-03-10 2009-09-16 The Procter and Gamble Company Compressed tablets
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
JP2012513475A (ja) * 2008-12-23 2012-06-14 レヴァイン，ジョシュア・ディー 薬物療法学養生法において感覚的な条件付け手がかり（ｓｅｎｓｏｒｙｃｏｎｄｉｔｉｏｎｉｎｇｃｕｅｓ）を付け加える方法
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
UA112411C2 (uk) 2010-03-26 2016-09-12 Філіп Морріс Продактс С.А. Пригнічення подразнення рецепторів при споживанні бездимних тютюнових виробів
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
NZ706991A (en) 2010-03-29 2016-08-26 Ferring Bv A fast dissolving pharmaceutical composition
EP2560626A4 (en) * 2010-04-21 2013-09-18 Teikoku Pharma Usa Inc EMULSIONAL COMPOSITIONS FOR LOCAL ANESTHESIA AND METHOD FOR THE PRODUCTION AND USE THEREOF
EP2387993B1 (en) * 2010-05-21 2012-11-07 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablets of zolmitriptan and process for preparing the same
US20110300216A1 (en) * 2010-06-03 2011-12-08 First Eric R Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives
RU2633640C2 (ru) 2011-09-16 2017-10-16 Ферринг Б.В. Быстрорастворимая фармацевтическая композиция
US10556011B2 (en) 2011-12-02 2020-02-11 Joshua D. Levine Method and system for adding sensory conditioning cues in a pharmacotherapeutic regimen
US9180104B2 (en) 2013-03-13 2015-11-10 Tris Pharma, Inc. Benzonatate modified release solid tablets and capsules
KR102290178B1 (ko) * 2013-03-13 2021-08-18 트리스 파마 인코포레이티드 벤조나테이트 변형 방출 고체 정제 및 캡슐
CN105012254A (zh) * 2015-06-10 2015-11-04 临汾奇林药业有限公司 一种羧甲司坦含片的生产工艺
RU2604575C1 (ru) * 2015-12-01 2016-12-10 Общество С Ограниченной Ответственностью "Валента-Интеллект" Фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний местного применения и способ ее получения и применения
RU2604576C1 (ru) * 2015-12-01 2016-12-10 Общество С Ограниченной Ответственностью "Валента - Интеллект" Фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний местного применения и способ ее получения и применения
US11110035B1 (en) * 2016-02-05 2021-09-07 Gram Tactical Llc Tactical medicine dispensers
US20200069607A1 (en) * 2016-12-07 2020-03-05 The Board Of Regents Of The University Of Texas System Mouthwash for treating oral cancers
US12053447B2 (en) * 2019-06-25 2024-08-06 NuBioPharma, LLC Oral solution and powder to liquid compositions of balsalazide
WO2021150178A1 (en) * 2020-01-23 2021-07-29 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Pharmaceutical compositions comprising ibuprofen, pseudoephedrine and ascorbic acid
US12551477B2 (en) * 2020-09-22 2026-02-17 Fertin Pharma A/S Oral antagonist compositions for nicotine burning relief

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515781A (en) * 1967-10-12 1970-06-02 Johnson & Johnson Cold capsule
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
US4822597A (en) * 1987-07-13 1989-04-18 Warner-Lambert Company Anesthetic-containing chewing gum compositions
US4853212A (en) * 1987-07-13 1989-08-01 Warner-Lambert Company Reduced base content chewing gum compositions having anesthetic properties
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
TW527195B (en) * 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
WO1999033445A1 (en) * 1997-12-29 1999-07-08 The Procter & Gamble Company Tablet composition
US20030206942A1 (en) * 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US20020022057A1 (en) * 2000-08-17 2002-02-21 Battey Alyce S. Oral delivery of pharmaceuticals via encapsulation
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10085954B2 (en) 2015-12-18 2018-10-02 The Procter & Gamble Company Quick dissolving diphenhydramine oral dosage form
US10624845B2 (en) 2015-12-18 2020-04-21 The Procter & Gamble Company Quick dissolving diphenhydramine oral dosage form

Also Published As

Publication number Publication date
CA2591747A1 (en) 2006-06-29
RU2007127999A (ru) 2009-01-27
EP1835886A1 (en) 2007-09-26
MX2007007885A (es) 2007-10-04
AU2005317739A1 (en) 2006-06-29
US20060141031A1 (en) 2006-06-29
WO2006067593A1 (en) 2006-06-29
JP2008525420A (ja) 2008-07-17
CN101102748A (zh) 2008-01-09

Similar Documents

Publication Publication Date Title
BRPI0519212A2 (pt) composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial
BRPI0414876A (pt) compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
BR0207930A (pt) Composições farmacêuticas lìquidas com sabor mascarado
UY27598A1 (es) Composiciones farmacéuticas de derivados de taxano oralmente activos que tienen biodisponibilidad mejorada
MX2010005175A (es) Comprimido dispersable oral.
MXPA05007643A (es) Metodo para producir una forma farmaceutica oral con desintegracion inmediata y liberacion de ingrediente activo.
BR0316170A (pt) Combinação, composição farmacêutica, uso de uma combinação, e, método para a profilaxia ou tratamento sinergìstico de câncer
CO5190672A1 (es) Composicion para la dosificacion oral, de disolucion instantanea
HN1999000210A (es) Composiciones de celecoxib
AU2003304237A8 (en) Gel-stabilized nanoparticulate active agent compositions
BR0005938A (pt) Composição de dosagem oral com libaraçãoprolongada
SG157406A1 (en) Oral medicament for the modified release of at least one active principle, in multi-microcapsule form
WO2008042480A3 (en) Epoxide inhibitors of cysteine proteases
BR0316236A (pt) Dispositivo polimérico de dissolução controlada para cavidade oral
BR0209327A (pt) Composição para tratamento de constipação induzida por drogas
BRPI0212298B8 (pt) composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico
BR9914419A (pt) Terapia para melhoria da percepção
BR0012696A (pt) Composição oftálmica
PE20150773A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
BRPI0417416A (pt) composição de confeitaria de branqueamento de dentes oral sólida
PA8571901A1 (es) Nueva composicion farmaceutica
MA27102A1 (fr) Composition pharmaceutique orodispersible d'ivabradine
BRPI0403461A (pt) composições estabilizadas contendo um agente ativo lábil ao oxigênio
BR0313177A (pt) Administração oral de calcitonina
WO2005074925A8 (en) Compositions substantially free of galactomannan containing piperacillin and tazobactam

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.